Tapewire

Nasdaq · USD

AGMB

AgomAb Therapeutics NV

Export transactions ↓
Tapewire entity
5259
SEC CIK
0002020932
Parsed reports
19

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202680

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 08, 2026 Filed Oct 9, 2026 12:01 UTC PurchaseCommon shares 5,000 $8.90 $44,500.00
Disclosure

SEC source: 0001445826-26-000014 · primary_doc.xml · nonDerivative · entry 1

Epstein David R · CIK 0001445826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 06, 2026 Filed Oct 7, 2026 12:57 UTC PurchaseCommon shares 5,000 $8.70 $43,500.00
Disclosure

SEC source: 0001445826-26-000013 · primary_doc.xml · nonDerivative · entry 2

Epstein David R · CIK 0001445826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 06, 2026 Filed Oct 7, 2026 12:47 UTC
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon shares 2,000 $8.54 $17,080.00
Disclosure

SEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 3

Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 06, 2026 Filed Oct 7, 2026 12:47 UTC
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon shares 5,000 $8.57 $42,850.00
Disclosure

SEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 2

Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 06, 2026 Filed Oct 7, 2026 12:47 UTC
Kemula Pierre Thadee VictorChief Financial Officer
PurchaseCommon shares 3,000 $8.67 $26,010.00
Disclosure

SEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 1

Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 06, 2026 Filed Oct 7, 2026 12:06 UTC
Knotnerus Tim JasperDirector · Chief Executive Officer
PurchaseCommon shares 5,000 $8.70 $43,500.00
Disclosure

SEC source: 0002120886-26-000001 · primary_doc.xml · nonDerivative · entry 2

Knotnerus Tim Jasper · CIK 0002120886 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,823

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 05, 2026 Filed Oct 7, 2026 12:57 UTC PurchaseCommon shares 5,000 $8.57 $42,850.00
Disclosure

SEC source: 0001445826-26-000013 · primary_doc.xml · nonDerivative · entry 1

Epstein David R · CIK 0001445826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
October 05, 2026 Filed Oct 7, 2026 12:06 UTC
Knotnerus Tim JasperDirector · Chief Executive Officer
PurchaseCommon shares 6,000 $8.48 $50,880.00
Disclosure

SEC source: 0002120886-26-000001 · primary_doc.xml · nonDerivative · entry 1

Knotnerus Tim Jasper · CIK 0002120886 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,823

F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:06 UTC GrantStock Option (Right to Buy) · Derivative 57,482 $0.00 Strike: $13.94 $0.00
Disclosure

SEC source: 0001104659-26-107916 · tm2625420-4_4seq1.xml · derivative · entry 1

Garcia Marino · CIK 0001669866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,482

Underlying: Common shares · 57,482 shares

Expires 2036-01-15

F1 · derivative.exercise_price: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

F2 · derivative.exercise_date: The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026.

F3 · derivative.underlying: 33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
September 11, 2026 Filed Sep 15, 2026 20:06 UTC GrantStock Option (Right to Buy) · Derivative 56,328 $0.00 Strike: $13.94 $0.00
Disclosure

SEC source: 0001104659-26-107915 · tm2625420-3_4seq1.xml · derivative · entry 1

Patel Naimish · CIK 0002021679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,328

Underlying: Common shares · 56,328 shares

Expires 2036-01-15

F1 · derivative.exercise_price: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.

F2 · derivative.exercise_date: The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026.

F3 · derivative.underlying: 33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.